OXFORD, England, Jan. 16, 2025 /PRNewswire/ -- Oxford Brain Diagnostics is proud to announce that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for CDM Insights. Powered by ...
Oxford Brain Diagnostics (OBD) is gearing up to launch a software tool designed to evaluate the early signs of dementia by analysing MRI scans. The UK company’s cloud-based Cortical Disarray ...
When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Signiant featured the new ability of Version 8.2 of its Content Distribution Management (CDM) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback